217 related articles for article (PubMed ID: 10768989)
1. Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.
Dacheux D; Toussaint B; Richard M; Brochier G; Croize J; Attree I
Infect Immun; 2000 May; 68(5):2916-24. PubMed ID: 10768989
[TBL] [Abstract][Full Text] [Related]
2. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
Hu H; Harmer C; Anuj S; Wainwright CE; Manos J; Cheney J; Harbour C; Zablotska I; Turnbull L; Whitchurch CB; Grimwood K; Rose B;
Clin Microbiol Infect; 2013 Mar; 19(3):266-72. PubMed ID: 22329595
[TBL] [Abstract][Full Text] [Related]
3. Pore-forming activity of type III system-secreted proteins leads to oncosis of Pseudomonas aeruginosa-infected macrophages.
Dacheux D; Goure J; Chabert J; Usson Y; Attree I
Mol Microbiol; 2001 Apr; 40(1):76-85. PubMed ID: 11298277
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.
Feltman H; Schulert G; Khan S; Jain M; Peterson L; Hauser AR
Microbiology (Reading); 2001 Oct; 147(Pt 10):2659-2669. PubMed ID: 11577145
[TBL] [Abstract][Full Text] [Related]
5. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.
Lee VT; Smith RS; Tümmler B; Lory S
Infect Immun; 2005 Mar; 73(3):1695-705. PubMed ID: 15731070
[TBL] [Abstract][Full Text] [Related]
6. Development of loop-mediated isothermal amplification assays for genotyping of Type III Secretion System in Pseudomonas aeruginosa.
Shi H; Chen Z; Kan J
Lett Appl Microbiol; 2015 Oct; 61(4):361-6. PubMed ID: 26219625
[TBL] [Abstract][Full Text] [Related]
7. Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes.
Berthelot P; Attree I; Plésiat P; Chabert J; de Bentzmann S; Pozzetto B; Grattard F;
J Infect Dis; 2003 Aug; 188(4):512-8. PubMed ID: 12898437
[TBL] [Abstract][Full Text] [Related]
8. Cell death of human polymorphonuclear neutrophils induced by a Pseudomonas aeruginosa cystic fibrosis isolate requires a functional type III secretion system.
Dacheux D; Attree I; Schneider C; Toussaint B
Infect Immun; 1999 Nov; 67(11):6164-7. PubMed ID: 10531282
[TBL] [Abstract][Full Text] [Related]
9. ExoS and ExoT ADP ribosyltransferase activities mediate Pseudomonas aeruginosa keratitis by promoting neutrophil apoptosis and bacterial survival.
Sun Y; Karmakar M; Taylor PR; Rietsch A; Pearlman E
J Immunol; 2012 Feb; 188(4):1884-95. PubMed ID: 22250085
[TBL] [Abstract][Full Text] [Related]
10. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
Finck-Barbançon V; Goranson J; Zhu L; Sawa T; Wiener-Kronish JP; Fleiszig SM; Wu C; Mende-Mueller L; Frank DW
Mol Microbiol; 1997 Aug; 25(3):547-57. PubMed ID: 9302017
[TBL] [Abstract][Full Text] [Related]
11. Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates.
Dacheux D; Attree I; Toussaint B
Infect Immun; 2001 Jan; 69(1):538-42. PubMed ID: 11119548
[TBL] [Abstract][Full Text] [Related]
12. The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum.
Pukatzki S; Kessin RH; Mekalanos JJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3159-64. PubMed ID: 11867744
[TBL] [Abstract][Full Text] [Related]
13. Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo.
Vance RE; Rietsch A; Mekalanos JJ
Infect Immun; 2005 Mar; 73(3):1706-13. PubMed ID: 15731071
[TBL] [Abstract][Full Text] [Related]
14. Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis.
Jain M; Ramirez D; Seshadri R; Cullina JF; Powers CA; Schulert GS; Bar-Meir M; Sullivan CL; McColley SA; Hauser AR
J Clin Microbiol; 2004 Nov; 42(11):5229-37. PubMed ID: 15528719
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells.
Hauser AR; Engel JN
Infect Immun; 1999 Oct; 67(10):5530-7. PubMed ID: 10496945
[TBL] [Abstract][Full Text] [Related]
16. The Pseudomonas aeruginosa Type III secretion system plays a dual role in the regulation of caspase-1 mediated IL-1beta maturation.
Galle M; Schotte P; Haegman M; Wullaert A; Yang HJ; Jin S; Beyaert R
J Cell Mol Med; 2008; 12(5A):1767-76. PubMed ID: 18081695
[TBL] [Abstract][Full Text] [Related]
17. A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates.
Wareham DW; Curtis MA
Int J Med Microbiol; 2007 Jul; 297(4):227-34. PubMed ID: 17412636
[TBL] [Abstract][Full Text] [Related]
18. Clinical Isolates of Pseudomonas aeruginosa from Chronically Infected Cystic Fibrosis Patients Fail To Activate the Inflammasome during Both Stable Infection and Pulmonary Exacerbation.
Huus KE; Joseph J; Zhang L; Wong A; Aaron SD; Mah TF; Sad S
J Immunol; 2016 Apr; 196(7):3097-108. PubMed ID: 26895832
[TBL] [Abstract][Full Text] [Related]
19. The Impact of ExoS on
Kroken AR; Chen CK; Evans DJ; Yahr TL; Fleiszig SMJ
mBio; 2018 May; 9(3):. PubMed ID: 29717012
[No Abstract] [Full Text] [Related]
20. Killing from the inside: Intracellular role of T3SS in the fate of Pseudomonas aeruginosa within macrophages revealed by mgtC and oprF mutants.
Garai P; Berry L; Moussouni M; Bleves S; Blanc-Potard AB
PLoS Pathog; 2019 Jun; 15(6):e1007812. PubMed ID: 31220187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
